Search

Meeting Coverage:

Aspen Retinal Detachment Society

ARDS: 2017

Predicting Response to Anti-VEGF Monotherapy

Pravin Dugel, MD, Timothy Murray, MD, MBA

Show Description +

Pravin Dugel, MD, joins Timothy Murray, MD, MBA, to discuss how best to identify patients with diabetic macular edema who do not respond to anti-VEGF monotherapy. Dr. Dugel, relying on a post-hoc analysis of the DRCR.net's Protocol I study, argues that data collected during the first three anti-VEGF treatments may reliably indicate how a patient will respond to anti-VEGF monotherapy in the coming years.

Posted: 3/07/2017

Up Next

Polypoidal Choroidal Vasculopathy

Polypoidal Choroidal Vasculopathy

Gregg Kokame, MD, Timothy Murray, MD, MBA

Surgery in Patients With Choroidal Melanoma

Surgery in Patients With Choroidal Melanoma

Ivana Kim, MD, Timothy Murray, MD, MBA

3-D Surgery and the Digital OR

3-D Surgery and the Digital OR

Allen Ho, MD, Timothy Murray, MD, MBA

Optogenetic Vision Restoration

Optogenetic Vision Restoration

Gary Abrams, MD, Timothy Murray, MD, MBA

Retinal Implants: The Next Wave

Retinal Implants: The Next Wave

Mark Humayun, MD, PhD, Timothy Murray, MD, MBA

Reoperations in Vitreoretinal Surgery

Reoperations in Vitreoretinal Surgery

Hugo Quiroz-Mercado, MD, Timothy Murray, MD, MBA

Long-term Anti-VEGF Therapy for DME

Long-term Anti-VEGF Therapy for DME

Timothy Murray, MD, MBA, Charles C. Wykoff, MD, PhD

Predicting Response to Anti-VEGF Monotherapy

Predicting Response to Anti-VEGF Monotherapy

Pravin Dugel, MD, Timothy Murray, MD, MBA

Back to All Videos

Predicting Response to Anti-VEGF Monotherapy

Pravin Dugel, MD, Timothy Murray, MD, MBA

Pravin Dugel, MD, joins Timothy Murray, MD, MBA, to discuss how best to identify patients with diabetic macular edema who do not respond to anti-VEGF monotherapy. Dr. Dugel, relying on a post-hoc analysis of the DRCR.net's Protocol I study, argues that data collected during the first three anti-VEGF treatments may reliably indicate how a patient will respond to anti-VEGF monotherapy in the coming years.

Posted: 3/07/2017

Please log in to leave a comment.

More From ARDS: 2017 Coverage

Polypoidal Choroidal Vasculopathy

Polypoidal Choroidal Vasculopathy

Gregg Kokame, MD, Timothy Murray, MD, MBA

Surgery in Patients With Choroidal Melanoma

Surgery in Patients With Choroidal Melanoma

Ivana Kim, MD, Timothy Murray, MD, MBA

3-D Surgery and the Digital OR

3-D Surgery and the Digital OR

Allen Ho, MD, Timothy Murray, MD, MBA

Optogenetic Vision Restoration

Optogenetic Vision Restoration

Gary Abrams, MD, Timothy Murray, MD, MBA

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARDS: 2017.